BRBI BR Partners S.A. ADSs (BRBI) Revenue History
Annual and quarterly revenue from 2023 to present
BRBI Revenue Over Time (2023–2024)
BRBI Revenue Growth History
1 of 1 years with positive growth- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- +13.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $3.18B | — |
| Q1 2025 | $1.95B | — |
BRBI Revenue Analysis (2023–2024)
Current Revenue & Growth
As of June 8, 2026, BRBI BR Partners S.A. ADSs (BRBI) generated trailing twelve-month (TTM) revenue of $5.13 billion. The most recent quarter (Q2 2025) recorded $3.18 billion in revenue, up 63.4% sequentially.
Historical Growth Trajectory
BRBI's historical revenue data shows various trends over time. BRBI BR Partners S.A. ADSs's highest annual revenue of $7.41 billion was recorded in 2024, an all-time high.
Peer Comparison
Compared to Financial Services sector peers — including PX, PIPR, and HLI. Compare BRBI vs PX →
BRBI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $5.1B | - | - | 3.2% | ||
| $34.0B | - | - | 26.3% | ||
| $1.9B | - | - | 20.2% | ||
| $2.4B | - | - | 21.0% | ||
| $1.5B | - | - | 18.1% | ||
| $3.2B | - | - | 13.0% |
BRBI Historical Revenue Data (2023–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $7.41B | - | $437.3M | 5.9% | $239.4M | 3.2% |
| 2023 | $6.56B | - | $313.3M | 4.8% | $200.2M | 3.1% |
What if you invested $1,000 in BRBI back in 2023?
Total return with dividends reinvested · 3+ years of data
Calculate ReturnsHow much would $100/month in BRBI be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs BRBI Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationBRBI vs BRK-A — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Berkshire Hathaway Inc..
Compare NowBRBI — Frequently Asked Questions
Quick answers to the most common questions about buying BRBI stock.
Is BRBI's revenue growth accelerating or slowing?
BRBI TTM revenue: $5.1B. YoY growth: N/A. 5-year CAGR: N/A.
What is BRBI's revenue history from 2023 to 2026?
BRBI BR Partners S.A. ADSs (BRBI) revenue history spans 2023 to 2026. TTM revenue as of 2026 is $5.1B, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is BRBI's long-term revenue growth rate (CAGR)?
BRBI BR Partners S.A. ADSs's 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for BRBI.
Why does BRBI's quarterly revenue fluctuate?
BRBI quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. BRBI BR Partners S.A. ADSs's revenue data from 2023 to 2026 shows full historical quarterly detail on this page.
How is BRBI's revenue distributed by segment?
BRBI reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does BRBI's revenue compare to industry peers?
BRBI BR Partners S.A. ADSs (BRBI) with TTM revenue of $5.1B and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.